Receptor-mediated activation of gastric vagal afferents by glucagon-like peptide-1 in the rat.
about
Regulation of glucose homeostasis by GLP-1The role of gut endocrine cells in control of metabolism and appetitePhysiological underpinnings of irritable bowel syndrome: neurohormonal mechanismsPhysiology of proglucagon peptides: role of glucagon and GLP-1 in health and diseaseGlucagon-like peptide 1 interacts with ghrelin and leptin to regulate glucose metabolism and food intake through vagal afferent neuron signalingGlucagon-like peptide-1 reduces pancreatic β-cell mass through hypothalamic neural pathways in high-fat diet-induced obese rats.Selecting GLP-1 agonists in the management of type 2 diabetes: differential pharmacology and therapeutic benefits of liraglutide and exenatideGlucagon-like peptides 1 and 2 and vasoactive intestinal peptide are neuroprotective on cultured and mast cell co-cultured rat myenteric neuronsExendin-4 and sitagliptin protect kidney from ischemia-reperfusion injury through suppressing oxidative stress and inflammatory reaction.Emerging role of GLP-1 receptor agonists in the treatment of obesity.Gastrointestinal hormones and the dialogue between gut and brain.Peripheral and central GLP-1 receptor populations mediate the anorectic effects of peripherally administered GLP-1 receptor agonists, liraglutide and exendin-4.The common hepatic branch of the vagus is not required to mediate the glycemic and food intake suppressive effects of glucagon-like-peptide-1.Circulating GLP-1 and CCK-8 reduce food intake by capsaicin-insensitive, nonvagal mechanisms.Peripheral neural targets in obesityMolecular mechanisms underlying nutrient-stimulated incretin secretion.Role of the glucagon-like-peptide-1 receptor in the control of energy balance.Nutrition and L and K-enteroendocrine cells.Obesity - an indication for GLP-1 treatment? Obesity pathophysiology and GLP-1 treatment potential.Sensing via intestinal sweet taste pathways.GLP-1 and energy balance: an integrated model of short-term and long-term controlThe effect of glucagon-like peptide 1 on cardiovascular risk.Ghrelin, the proglucagon-derived peptides and peptide YY in nutrient homeostasis.Review article: a comparison of glucagon-like peptides 1 and 2.Incretin hormones and the satiation signal.Do we know the true mechanism of action of the DPP-4 inhibitors?Exogenous glucagon-like peptide-1 acts in sites supplied by the cranial mesenteric artery to reduce meal size and prolong the intermeal interval in rats.Ability of GLP-1 to decrease food intake is dependent on nutritional status.Differential hypoglycaemic, anorectic, autonomic and emetic effects of the glucagon-like peptide receptor agonist, exendin-4, in the conscious telemetered ferret.Sensory Neurons that Detect Stretch and Nutrients in the Digestive System.The effect of glucagon-like peptide-1 in the management of diabetes mellitus: cellular and molecular mechanisms.Leptin directly depolarizes preproglucagon neurons in the nucleus tractus solitarius: electrical properties of glucagon-like Peptide 1 neurons.Characterisation of oral and i.v. glucose handling in truncally vagotomised subjects with pyloroplasty.Increased expression of glucagon-like peptide-1 receptors in psoriasis plaques.The gut as a sensory organ.Impaired intestinal afferent nerve satiety signalling and vagal afferent excitability in diet induced obesity in the mouse.Bariatric surgery - time to replace with GLP-1?Meal-Sensing Signaling Pathways in Functional Dyspepsia.Targeting the intestinal L-cell for obesity and type 2 diabetes treatmentThe effect of exogenous GLP-1 on food intake is lost in male truncally vagotomized subjects with pyloroplasty
P2860
Q24563430-17EDC54A-59BB-432E-A20C-4903F68C5058Q26824311-F7122C9B-8490-47C9-A5D9-8F4D7BCA88B8Q26830683-FD939ED1-DD9E-4B10-B5C6-939D722F404FQ27027920-B27C4BC8-E098-455C-B154-8CAD1485AEECQ28084873-B78B020C-C032-4412-BC54-1B740FF4EDE9Q33911780-B13156CA-D9B6-42A5-AFF6-0F36466F8FC9Q34133324-CFDF3BD0-3E16-4E0F-905D-C5713533361FQ34215215-D6293CB6-0476-4050-A479-02502B7DFBEDQ34508051-CA63B03E-E109-46A0-8A6D-B37E14CC8BD3Q34620465-7D19D7E6-70C6-48E0-ACFA-64B42BEA7CBFQ35102422-B36CCCB7-1C73-480F-B4E0-36871C3D25BBQ35110843-4A74D144-47EB-4C30-8A55-086979253D9CQ35543398-ECE941B5-9C6E-487B-9A4E-808167D98C79Q35950315-69BB4F33-6D32-4734-838A-F82482CA5976Q36166645-D0CC5DCC-65AA-4098-AEE3-1D698BE88176Q37667168-279D4B22-5AB2-4CC5-B6CE-6421376DD9E6Q37708356-71711B83-8B31-43D8-9111-2272E4D9FEB2Q37814881-42A840EF-8292-4EA1-B594-38E512E2CCF5Q37852801-638BA26E-539A-4B9E-9396-D128BC7734C0Q37868939-A04B936E-ED19-4A39-AAC9-0BE23E03AE77Q37885717-9B54D3DE-EB96-466A-8632-6D4B9ECF60AAQ37980019-5FC58371-ABEC-4A60-A164-F0BE5A674002Q38048602-B2325AC9-BFDD-4F54-82EC-5E934FB8D477Q38057350-B5305785-4F9D-4235-AA5F-44BEDA06BD2CQ38072203-794FE055-22EB-487D-BDCA-26A13456CAE0Q39329866-EBE21D84-EF61-4EE7-9301-601EDDEDB37AQ41449397-FB561815-7FF0-4D0F-9E99-D4D8205E8912Q41821895-58897330-6C52-4668-A7B3-FF57EA5D8188Q41949833-DDB61D63-2BDF-4856-B30E-C5632A586399Q42176581-9C0CF8DF-BA36-44F5-A1F2-2075324390C1Q42463784-8F21E954-74F4-4F28-B7C5-EBBE86497842Q42684124-E36B6C26-5BF3-42C6-9116-C74035933B4AQ43094716-3FFDE581-450F-43EF-B24C-D84DC2B3CBA8Q44120881-32606AA3-EA26-4258-9415-56C24735027EQ45894561-E9529653-13D3-4D8D-B6BB-C9292CB900C9Q50278777-CC86CBA9-957C-4AEF-B69C-9858011D2862Q50853618-16F71284-EE4B-487B-BA6B-D64D10731990Q54939638-3E7A8BEA-71CC-44A9-AD3C-A172D9E3CB66Q58447645-D721279D-AFDC-4C2C-82A4-19DC3CC29E53Q58447745-16B65EF1-0E0D-4F27-9012-854852AC9BD4
P2860
Receptor-mediated activation of gastric vagal afferents by glucagon-like peptide-1 in the rat.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
2009年论文
@zh
2009年论文
@zh-cn
name
Receptor-mediated activation o ...... gon-like peptide-1 in the rat.
@en
Receptor-mediated activation o ...... gon-like peptide-1 in the rat.
@nl
type
label
Receptor-mediated activation o ...... gon-like peptide-1 in the rat.
@en
Receptor-mediated activation o ...... gon-like peptide-1 in the rat.
@nl
prefLabel
Receptor-mediated activation o ...... gon-like peptide-1 in the rat.
@en
Receptor-mediated activation o ...... gon-like peptide-1 in the rat.
@nl
P2093
P1476
Receptor-mediated activation o ...... gon-like peptide-1 in the rat.
@en
P2093
B Rydqvist
J Pedersen
P M Hellström
V Bucinskaite
P304
P356
10.1111/J.1365-2982.2009.01317.X
P577
2009-05-13T00:00:00Z